Overview
CaRi-Heart and CaRi-Plaque AI analysis of coronary CT angiography detecting inflammation, plaque burden, and individualized cardiovascular risk scores from standard cardiac CT workflows.
Product and company
Caristo Diagnostics — Medical Imaging is a verified product offering linked to the Brel Digital company profile for Caristo Diagnostics.
Use cases
CaRi-Heart and CaRi-Plaque AI analysis of coronary CT angiography detecting inflammation, plaque burden, and individualized cardiovascular risk scores from standard cardiac CT workflows.
Target customer
Cardiology clinics, preventive screening programs, NHS trusts, commercial insurers, and pharmaceutical partners running cardiovascular outcome studies.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.
Sources and references
- Official product / company source: https://www.caristo.com/caristo-diagnostics-appoints-stephen-deitsch-as-chief-executive-officer/
- Supporting source: https://www.caristo.com/caristo-management/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- CaRi-Heart and CaRi-Plaque AI analysis of coronary CT angiography detecting inflammation, plaque burden, and individualized cardiovascular risk scores from standard cardiac CT workflows.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.